12-11-2024
Source: EGX
Company Name : Macro Group Pharmaceuticals -Macro Capital
ISIN Code : EGS7D971C011
Currency : EGP
F/S Standalone Period : From 01/01/2024 To 30/09/2024
Net Loss : 64,442,930
F/S Standalone Period : From 01/01/2023 To 30/09/2023
Net Comparative Profit : 100,348,097
Audit Status : Reviewed
Source : Macro Group Pharmaceuticals -Macro Capital
The Financial Statements in Arabic (4,001 KB)
The Financial Statements in English (5,204 KB)
EGX30
Advancing : Declining 0 : 1
shares
Sector Name | T/O (EGP Mn) | Mkt % |
Financial Services and Electronic Payments | 847.08 | 21.49 |
Real Estate and Hotels | 814.28 | 20.66 |
Industrial, Construction and Materials | 790.09 | 20.05 |
Banks | 353.14 | 8.96 |
Chemicals | 242.10 | 6.14 |
Consumer Discretionary | 218.59 | 5.55 |
Food and Beverage | 177.76 | 4.51 |
Other | 133.54 | 3.39 |
Healthcare and Pharmaceuticals | 130.28 | 3.31 |
Transportation, Shipping and Logistics | 101.77 | 2.58 |
Energy | 67.94 | 1.72 |
Technology, Media and Telecom | 38.82 | 0.98 |
Education | 25.46 | 0.65 |